To access this element change to forms mode OFF
Grant Award View - GA268546
Generating evidence to improve use of immunoglobulin replacement to...
GA ID:
GA268546
Agency:
Department of Health and Aged Care
Approval Date:
7-Apr-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
7-Apr-2022 to 31-Mar-2027
Value (AUD):
$3,984,139.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Generating evidence to improve use of immunoglobulin replacement to reduce infections in blood cancers: the RATIONAL Platform Trial
Purpose:
Patients with blood cancers often have low levels of antibodies needed to fight infections, both due to their underlying blood cancer and also due to their cancer treatments. In this study, we will evaluate two commonly provided treatments - replacement of antibodies with a blood product (called immunoglobulin) and antibiotic therapy - to determine which treatments are most effective at reducing infections and which patients are most likely to benefit from the treatments.
GO ID:
GO Title:
MRFF – PPHRI – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity
Internal Reference ID:
2022/MRF2018373
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, TAS
Postcode:
Multiple
Country:
AUSTRALIA